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The objective of this study was to evaluate mitochondrial alterations in a cell-based model of myocardial ischemia/reperfusion (I/R) injury.
Using GFP-biosensors and fluorescence deconvolution microscopy, we investigated mitochondrial morphology in relation to Bax and Bid
activation in the HL-1 cardiac cell line. Mitochondria underwent extensive fragmentation during ischemia. Bax translocation from cytosol to
mitochondria was initiated during ischemia and proceeded during reperfusion. However, Bax translocation was not sufficient to induce cell death
or mitochondrial dysfunction. Bid processing was caspase-8 dependent, and Bid translocation to mitochondria occurred after Bax translocation
and clustering, and minutes before cell death. Clustering of Bax into distinct regions on mitochondria could be prevented by CsA, an inhibitor of
the mitochondrial permeability transition pore, and also by SB203580, an inhibitor of p38 MAPK. Surprisingly, mitochondrial fragmentation
which occurred during ischemia and before Bax translocation could be reversed by the addition of the p38 inhibitor SB203580 at reperfusion.
Taken together, these results implicate p38 MAPK in the mitochondrial remodeling response to I/R that facilitates Bax recruitment to
mitochondria.
© 2006 Elsevier B.V. All rights reserved.Keywords: Ischemia; Reperfusion; Cell death; Mitochondria; Bid; Bax1. Introduction
1.1. Cardiac injury due to ischemia reperfusion
Under physiological conditions, apoptosis, a highly regulat-
ed form of programmed cell death (PCD), serves to remove
damaged or unneeded cells and maintain a balance between cell
proliferation and death. PCD involves either the activation ofAbbreviations: sI/R, simulated ischemia/reperfusion; ROS, reactive oxygen
species; MPTP, mitochondrial permeability transition pore; TMRM, tetra-
methylrhodamine methyl ester; CM-DCF, chloromethyl-dichlorofluorescein;
KH, Krebs–Henseleit; FP, fluorescent protein
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pathways, with convergence of pathways occurring at the
level of caspase activation [1].
Ischemia/reperfusion (I/R) injury results in cell death of
cardiac myocytes, a terminally differentiated cell type, and
consequently reduced myocardial function. In vivo and in
vitro models have shown that mitochondria are regulators of
I/R-activated PCD. They sense a wide range of perturbations
to cellular homeostasis, and can switch from their role as
providers of the majority of ATP, to initiators of apoptosis
[2]. Important parameters of mitochondrial dysfunction are
loss of mitochondrial membrane potential (ΔΨ), the driving
force for ATP generation, and enhanced production of
reactive oxygen species (ROS). Downstream events include
the mitochondrial permeability transition (MPT) and the
release of pro-apoptotic signaling components, such as
cytochrome c, from the mitochondria, which in turn activate
the caspase signaling cascade.
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At the level of the single mitochondrion, both mitochondrial
permeability transition pore (MPTP) activity and mitochondrial
outer membrane permeability (MOMP) are regulated by two
opposing classes of the Bcl-2 family. The anti-apoptotic
members, including Bcl-2 and Bcl-xL which posses four Bcl-2
homology domains (BH1–BH4), act to stabilize the MPTP and
have been shown to block the release of mitochondrial
apoptogenic factors following a cell death stimuli. It is thought
that Bid binds toBcl-2 andBcl-xL to form heterodimers with, and
thereby inactivate, pro-apoptotic Bcl-2 family members [3–5].
1.3. Pro-apoptotic Bcl-2 family members
The pro-apoptotic members either contain three Bcl-2
homology domains (BH1–BH3; e.g., Bax and Bak) or a single
BH3 domain (e.g., Bid and Bnip3). During I/R injury Bax and
Bid play crucial roles in the commitment to cell death, as
demonstrated in both Bid [6] and Bax [7] knockout mice where
infarct following ischemia/reperfusion in the isolated heart was
reduced by around 63% and 51%, respectively. Bax and Bid
reside largely in the cytosol (or loosely bound to the
mitochondria) and translocate to the mitochondria following a
pro-death stimulus [8,9]. Once activated, Bax undergoes a
conformational change, allowing for its C-terminal end to be
inserted into the mitochondrial outer membrane [10,11].
Membrane insertion is followed by oligomerization, an event
thought to precede cytochrome c release [12,13]. Bid lies within
the extrinsic death receptor pathway, and upon its activation
serves to bridge the intrinsic and extrinsic pathways. Following
TNFα or Fas treatment, Bid is cleaved by caspase-8 generating
the C-terminal product tBid, which is myristoylated and
translocates to the mitochondria [14]. Bid has been proposed
to both directly participate in the MOMP event [15], as well as
amplify the pro-apoptotic signaling of Bax either through direct
interaction with Bax/Bak [14,16], or through scavenging of Bcl-
2 and Bcl-xL, which oppose Bax activity. Recently, Bid
activation has been shown to result in lysosomal destabilization
[17,18], indicating that Bid may also bridge the apoptotic and
autophagic cell death signaling pathways.
The dynamics of Bax and Bid activation, in relation to
mitochondrial dysfunction are unclear in the context of I/R
injury in the heart. In the study presented here, we investigated
the spatio-temporal kinetics of Bid activation and action in
relation to Bax translocation and aggregation, and mitochon-
drial fragmentation. We utilized simulated ischemia/reperfusion
(sI/R) for single-cell analysis of HL-1 cardiac myocytes using a
variety GFP-derived fusion proteins and multidimensional
fluorescence deconvolution microscopy.2. Materials and methods
2.1. Cell culture and transfections
Cells of the atrial-derived cardiac cell line HL-1 [19] were plated in
gelatin/fibronectin-coated culture vessels and maintained in Claycombmedium (JRH Biosciences) supplemented with 10% fetal bovine serum,
0.1 mM norepinephrine, 2 mM L-glutamine, 100 U/ml penicillin, 100 U/ml
streptomycin, and 0.25 μg/ml amphotericin B. Cells were transfected with
the indicated vectors using the transfection reagents Effectene (Qiagen) or
Lipofectamine 2000 (Invitrogen) according to the manufacturer's instruc-
tions, achieving approximately 40% and 60% transfection efficiency,
respectively.
2.2. Plasmid construction
2.2.1. pmCherry-C1
mCherry was amplified from the pRSET-mCherry vector [20], with the
forward (5′-GTAACCGGTATGGTGAGCAAGGGCGAG-3′) and reverse (5′-
GTAAGATCTCTTGTACAGCTCGTCCATGC-3′) primers (Allelebiotech La
Jolla). AgeI and BglII restriction sites were added to 5′ and 3′ cDNA ends,
respectively (underlined). mCherry was swapped with EGFP of the vector
pEGFP-C1, generating the pmCherry-C1 vector.
2.2.2. mCherry-Bax(WT) and mCherry-Bax(T182A)
Human Baxα was amplified from pEGFP-Bax [21], with the forward (5′-
GTAAGATCTATGGACGGGTCCGGGGAG-3′) and reverse (5′- GTA-
GAATTCTCAGCCCATCTTCTTCCAGATGGTG-3′) primers BglII and
EcoRI restriction sites were added to 5′ and 3′ cDNA ends, respectively
(underlined), Human Baxα was inserted into pmCherry-C1 at the BglII and
EcoRI restriction sites. The threonine 182 to alanine (T182A) point mutation
within human Baxα was generated using site directed mutagenesis. The T182A
mutation was inserted using the forward primer 5′-GGGAGTGCTCG-
CCGCCTCACTCACCATCTGG-3′ and its complementary reverse primer.
The construct was inserted into the pmCherry-C1 vector.
2.2.3. Mito-ECFP
ECFP was excised from pECFP-N1 at restriction sites BamHI and NotI.
DsRed2 was removed from the pDsRED2-Mito vector (Clonetech) at restriction
sites BamHI and NotI, and replaced with ECFP to generate the mito-ECFP
vector.
2.2.4. YFP-Bid-CFP (WT and Δcasp8)
YFP-Bid-CFP was generated using the improved version of YFP, Venus
[22], and CFP, Cerulean [23]. Human full-length Bid, Venus, and Cerulean were
amplified by PCR using end primers containing the required restriction sites to
generate YFP-(XhoI)-Bid-(SphI)-CFP. The obtained ligation product was
subcloned into pcDNA3.1(+) using the KpnI and NotI sites.
To generate YFP-BidΔcasp8-CFP, full-length Bid was exchanged against
BidΔcasp8 which had been obtained via site directed mutagenesis of the caspase
8 cleavage site using the forward primer 5′-GAGCTGCAGACTGAGGG-
CAACCGCAGCAGC-3′ and the complementary reverse primer 5′-
GCTGCTGCGGTTGCCCTCAGTCTGCAGCTC-3′.
2.3. Simulated ischemia/reperfusion (sI/R)
For real-time fluorescence imaging, cells were plated on 25-mm-
diameter round glass coverslips. The coverslips were placed in an air-tight
Leiden perfusion chamber (Harvard Apparatus), mounted on the stage of a
fluorescence microscope and subjected to 1–2 h of simulated ischemia by
superfusion with ischemia-mimetic solution (in mM: 125 NaCl, 8 KCl, 1.2
KH2PO4, 1.25 MgSO4, 1.2 CaCl2, 6.25 NaHCO3, 5 Na-lactate, 20 HEPES,
pH 6.6) equilibrated with 95% N2–5% CO2, followed by reperfusion with
normoxic Krebs–Henseleit solution (KH, in mM: 110 NaCl, 4.7 KCl, 1.2
KH2PO4, 1.25 MgSO4, 1.2 CaCl2, 25 NaHCO3, 15 glucose, 20 HEPES,
pH 7.4) equilibrated with 95% O2–5% CO2. Alternatively, cells were
plated in 14-mm-diameter glass bottom microwell dishes (MatTek) and
ischemia was introduced by a buffer exchange to ischemia-mimetic solution
and placing of the dishes in hypoxic pouches (GasPak™ EZ, BD
Biosciences). After 2 h of ischemia, reperfusion was initiated by a buffer
exchange to normoxic KH solution and incubation at 95% O2–5% CO2.
Controls incubated in normoxic KH solution were run in parallel for each
condition. Under control conditions in KH solution cell viability was not
compromised.
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Cells were observed through a Nikon TE300 fluorescence microscope
(Nikon) equipped with a 10× lens (0.3 N.A., Nikon), a 40× Plan Fluor and a 60×
Plan Apo objective (1.4 N.A. and 1.3 N.A. oil immersion lenses; Nikon), a Z-
motor (ProScanII, Prior Scientific), a cooled CCD camera (Orca-ER,
Hamamatsu) and automated excitation and emission filter wheels controlled
by a LAMBDA 10-2 (Sutter Instrument) operated by MetaMorph 6.2r4
(Universal Imaging).
For high-resolution microscopy, Z-stacks of representative cells were
acquired at 60× magnification with 0.3 μm increments. Acquired wide-field
Z-stacks were routinely deconvolved using a 3D blind deconvolution
algorithm (AutoQuant) to maximize spatial resolution. Representative cells
are shown as maximum projections of 3D-deconvolved Z-stacks, unless stated
otherwise.
2.5. Detection of ROS and mitochondrial membrane potential (ΔΨm)
Intracellular ROS levels were assessed using chloromethyl-dichlorodihy-
drofluorescein diacetate (CM-DCFH2-DA), which is predominantly retained
inside mitochondria due to covalent binding of the probe's chloromethyl moiety
to the abundant sulfhydryl groups in the mitochondrial matrix [24]. ΔΨm was
assessed using tetramethylrhodamine methyl ester (TMRM) or Rhodamine123
(Rhod123), which electrophoretically accumulate in the matrix of actively
respiring mitochondria and are released once ΔΨm is impaired [25]. For dye-
loading, CM-DCFH2-DA (10 μM) was added to the cells prior to sI/R in KH
buffer and allowed to load for 30 min at room temperature to ensure
mitochondrial loading of CM-DCFH2-DA. TMRM (5 nM) was included in the
ischemia-mimetic solution or, in normoxic control cells, the KH solution
paralleling the experimental duration of 2 h ischemia simulation. Cells
expressing either mCherry-Bax or mCherry-BaxT182A were incubated 30 min
with 50 nM Rhod123 at 37 °C in HL-1 medium prior to imaging in dye-free KH
solution.
2.6. Assessment of mitochondrial morphology
To visualize mitochondria independently of ΔΨm, cells were transfected
with a plasmid encoding mito-DsRed2 (Clontech) or mito-ECFP, in which the
fluorescent proteins DsRed2 or ECFP are fused to the COX IV targeting
sequence, thus targeting them to the mitochondrial inner membrane [26].
2.7. Quantification of cellular injury
GFP-Bax [21]or mCherry-Bax distribution was used as a parameter to
quantify irreversible cellular injury. Cells were transfected with mCherry-Bax or
GFP-Bax and allowed to express for 48 h. Then, cells were subjected to 2 h
ischemia in hypoxic pouches followed by 5 h reperfusion and live cells were
analyzed by fluorescence microscopy. Cells were classified as cells with (i)
diffuse or (ii) punctate mitochondrial (mCherry-)GFP-Bax fluorescence. Per
condition, a total of approximately 250–500 transfected cells were scored at 40×
or 60× magnification in three independent experiments.
2.8. Immunoblotting
Cells were harvested by scraping and centrifugation at 550×g for 5 min at
4 °C and washed once with cold PBS (pH 7.4). To prepare whole cell lysates,
cell pellets were solubilized in cold RIPA buffer (50 mM Tris–HCl (pH 7.4),
150 mM NaCl, 1% Triton-X 100, 0.1% SDS, 1 mM EDTA, 1 mM Na3VO4,
1 mM NaF, and protease inhibitor cocktail (Roche)) and left on ice for 15 min.
The cell extracts were centrifuged at 20 000×g for 5 min to remove cellular
debris.
After addition of sample buffer and reducing agent (BioRad) samples were
incubated at 95 °C for 5 min, electrophoresed on a 10%Bis–Tris SDS-PAGE gel
and transferred to nitrocellulose membranes (BioRad). Immunodetection was
performed using antibodies against Bid (R&D Systems), Bax (N-20; Santa
Cruz), Fluorescent Protein (FP; BD Biosciences), RhoGDI (BD Biosciences),
and actin (clone AC-40; Sigma).2.9. Statistics
The probability of significant differences between experimental groups was
determined by the Student's t test. Values are expressed as mean±S.E.M. of at
least three independent experiments unless stated otherwise.
2.10. Reagents
CsA, ALLN, zVAD-fmk, TNF-α and SB203580 hydrochloride were
purchased from EMD Biosciences. Fluorescent dyes were purchased from
Invitrogen.3. Results
3.1. Simulated I/R in HL-1 cardiac myocytes
When using myocyte cell lines (H9c2, C2C12) and cultured
neonatal cardiac myocytes, prolonged (from 8 to 24 h)
hypoxia or simulated ischemia are required to activate death
signaling pathways [27–29]. Alternatively, oxidizing agents,
e.g., H2O2, or initiators of apoptosis, e.g., staurosporine, are
employed as surrogates to explore I/R injury [30,31]. We
sought to establish an acute model which closely resembles the
in vivo signaling pathways during I/R injury to the heart,
focusing on the HL-1 cell line which has been described as a
successful model for studying many aspects of cardiac cell
physiology [32].
To simulate ischemia, which is characterized by a reduction
in the supply of oxygen and nutrients, resulting in lactate
accumulation and intracellular acidosis, cells were bathed in a
hypoxic, glucose-free, lactate-containing acidic KH solution
(pH 6.6) containing 2-deoxyglucose to inhibit glycolysis [33].
Following an ischemic period of 2 h, reperfusion was initiated
by exchanging the ischemic solution with normoxic KH
solution. Under control conditions, where cells were maintained
in normoxic KH solution for the duration of the experiment, cell
viability was not compromised. In response to sI/R, however,
HL-1 cells reproducibly underwent cell death over a time-
course of several hours (data not shown), as determined by
plasma membrane permeability to YoPro1 and propidium
iodide [34,35].
Mitochondrial dysfunction, characterized by the generation
of reactive oxygen species (ROS) and loss of mitochondrial
membrane potential (ΔΨ m), is a critical feature of I/R injury
[2,36]. Preservation of mitochondrial integrity is essential for
energy homeostasis and survival of the cardiac myocyte, while
compromised mitochondrial integrity ultimately leads to the
conversion of mitochondria into executers of programmed cell
death. We investigated whether our model of sI/R activated
classic parameters of mitochondrial dysfunction.
We found that 90 min after reperfusion, HL-1 cells
displayed decreased ΔΨm, as indicated by decreased TMRM
fluorescence, as well as enhanced mitochondrial ROS
generation, as indicated by increased mitochondrial-concen-
trated CM-DCF fluorescence (Fig. 1). Notably, sI/R-activated
ROS production and ΔΨm collapse occurred heterogeneously
within the population of HL-1 cells. The HL-1 cell line
responds to 2 h simulated ischemia and 90 min reperfusion
Fig. 1. sI/R in HL-1 cardiac myocytes leads to mitochondrial dysfunction. HL-1 cells were loaded with 10 μM CM-DCFH2-DA and subjected to 2 h ischemia in the
presence of 5 nM TMRM. Following, reperfusion was introduced by a buffer exchange to dye-free KH solution. At 90 min of reperfusion, TMRM (upper panels) and
CM-DCF (lower panels) fluorescence were compared to normoxic control cells, which had been identically treated with dyes, to assess ΔΨm and ROS levels,
respectively. Representative images were acquired at 20× magnification under the exact same conditions to ensure comparability. Multicolor look up tables (LUT)
were applied to grey scale images to visualize the range of fluorescence intensities with black representing lowest pixel values and white representing highest pixel
values. Scale bars, 50 μm.
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neonatal myocytes or H9c2 cells. In this respect, it more
closely resembles adult cardiomyocytes which initiate similar
responses after 30 min simulated ischemia and 90 min
reperfusion. The production of ROS and mitochondrial
depolarization also recapitulate well characterized events in
myocardial I/R injury.
3.2. Mitochondrial dysfunction and fragmentation
The modulation of mitochondrial morphology is an
important parameter of mitochondrial function. Recent studies
have shown that during programmed cell death induced by
staurosporine [37], metabolic inhibition [38], or H2O2 [39],
fragmentation of the mitochondrial network is a consistent
feature.
Using mitochondrial-targeted fluorescent markers for mito-
chondria, either mito-DsRed2 or mito-ECFP, we assessed
mitochondrial morphology during sI/R-induced injury using
high resolution imaging. Prior to the ischemic insult, mito-
DsRed2-labeled mitochondria were observed as elongated,
branched organelles, whereas mitochondrial fragmentation
occurred during ischemia and persisted during reperfusion
(Fig. 2). Cells incubated under control conditions (in KH
solution) remained filamentous for more than 24 h (data not
shown). These results indicate that a process of dramatic
mitochondrial remodeling is initiated during simulated
ischemia.3.3. Bax translocation and clustering
The pro-apoptotic Bcl-2 family member Bax is an important
participant in sI/R-induced apoptosis [40]. Under normal
conditions in HL-1 cells, Bax is found homogeneously
distributed throughout the cytoplasm. Bax translocates to the
mitochondria in response to staurosporine [31] and chemical
hypoxia [41].
Using constructs encoding human Baxα fused to either EGFP
(GFP-Bax) [21] or monomeric red fluorescing mCherry [20],
(mCherry-Bax), we investigated Bax translocation and cluster-
ing on mitochondria in response to sI/R. Under normal
conditions GFP-Bax was homogeneously distributed throughout
the cytosol (Fig. 3). During the 2 h ischemic treatment, GFP-Bax
translocated in only a few cells (∼15%, data not shown). The
majority of GFP-Bax translocation to the mitochondria occurred
during reperfusion. We found that GFP-Bax formed punctate
foci, or clusters [11,42], at or on fragmented mitochondria (Fig.
3A). Identical results were obtained with mCherry-Bax.
Quantification of Bax clustering was performed after 5 h
reperfusion. Mitochondrial depolarization occurred following
mitochondrial fragmentation but prior to Bax clustering.
Mitochondrial depolarization is often a result of the
mitochondrial permeability transition (MPT). To assess whether
Bax clustering caused or was a result of the MPT, we treated
HL-1 cells with CsA (1 μM). This intervention significantly
reduced sI/R-induced GFP-Bax clustering (Fig. 3B), indicating
that MPT was upstream of Bax clustering.
Fig. 2. sI/R causes the disruption of the mitochondrial network. HL-1 cells were
subjected to sI/R in the Leiden perfusion chamber mounted to the stage of the
fluorescence microscope and mitochondrial dynamics were monitored by 4D-
imaging of mito-DsRed2 with 20 min intervals between frames. During
normoxic conditions prior to ischemia, mitochondria were branched and
elongated (upper panel). sI/R-induced fragmentation of the mitochondrial
network (lower panels).
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To further explore the two phases of Bax activation
(translocation and clustering), we transiently expressed a C-
terminal threonine-to-alanine point mutant of Bax (T182A)
fused to mCherry (mCherry-BaxT182A). BaxT182A has been
recently shown to spontaneously translocate to mitochondria
and in some cell types can trigger apoptosis [43]. The
translocation of Bax to mitochondria is a prerequisite for
mitochondrial outer membrane permeabilization for cyto-
chrome c release as well as for the MPTP [12,13].
In HL-1 cells, the majority of mCherry-BaxT182A was
associated with the mitochondria even under basal conditions
(Fig. 4A). Interestingly, in the absence of sI/R, cells transfected
with either mCherry-Bax or mCherry-BaxT182A exhibited
polarized, filamentous mitochondria, indicating intact mitochon-
drial function (Fig. 4B). Moreover, for up to 4 days following
transfection, BaxT182A was not sufficient to induce apoptosis in
HL-1 cells. We therefore asked whether the mitochondrial
localization of Bax sensitized cells to sI/R injury. Bax-mCherryclustering was quantified at time points (2.5 and 5 h of
reperfusion). At 2.5 h of reperfusion, mCherry-Bax and
mCherry-BaxT182A clustering was 15% and 23%, respectively
However, at 5 h of reperfusion,mCherry-BaxT182A clusteringwas
significantly higher than for mCherry-Bax, 41% and 66%,
respectively (Fig. 4C). These results indicate that Bax transloca-
tion itself is not sufficient to induce mitochondrial fragmentation
or depolarization, but that it may sensitize the mitochondria to
injury or shorten the interval to complete apoptosis. Thus, Bax
translocation may be regarded as a priming event.
p38α is an established participant in I/R activated PCD in the
heart [44] Moreover, treatment with p38 inhibitors can block
nitric oxide-induced Bax activation [45]. To determine the effect
of p38 on Bax translocation and clustering in our model of sI/R,
we added the p38 inhibitor SB203580 at reperfusion. Inhibition
of p38 significantly blunted mCherry-Bax translocation and
clustering. To determine if p38 was required just for transloca-
tion or if it was also required for clustering, we evaluated the
effect of SB203580 on mCherry-BaxT182A, (Fig. 4C). As
previously observed, mCherry-BaxT182A spontaneously associ-
ated with mitochondria; however, the addition of SB203580 at
reperfusion prevented clustering. Taken together, these results
indicate a role for p38 in both steps in Bax activation.
In addition, we noted that while > 90% of mitochondria were
fragmented at the end of ischemia, a morphology that persisted
beyond 5 h reperfusion, cells treated with SB203580 at
reperfusion exhibited filamentous mitochondria at 5 h, indicat-
ing that the filamentous mitochondrial network had re-formed
(Fig. 4D). This suggests that p38 may play an active role in
regulating mitochondrial structure during ischemia and
reperfusion.
3.5. Bid activation in sI/R monitored by a GFP biosensor
We have previously shown that the BH3-only protein Bid is
cleaved by calpain to its active form during myocardial ischemia/
reperfusion [46]. To explore the kinetics of sI/R-induced Bid
activation in a time and spatially resolvedmanner, we constructed
a GFP-based biosensor, in which full-length Bid is flanked by
YFP at the N-terminus and CFP at the C-terminus (YFP-Bid-
CFP). This was chosen in order to enable tracking of both the N-
and C-terminal fragments of Bid. Under control conditions, both
YFP and CFP fluorescence were distributed homogeneously
throughout the cell (Fig. 5A) consistent with the cytosolic
distribution of Bid in healthy cells. In cells which had been
subjected to simulated ischemia followed by prolonged hours of
reperfusion (+ 6 h), however, YFP-Bid displayedmainly a diffuse
cytosolic staining pattern while C-terminal Bid-CFP (containing
the BH3 domain) was found at distinct subcellular regions (Fig.
5A). Dual imaging of mito-DsRed and tBid-CFP identified
mitochondria as the subcellular targets of Bid (Fig. 5B).
3.6. sI/R-induced cardiac myocyte Bid cleavage is mediated by
caspase 8
Bid can be cleaved by various proteases such as caspase
8 [15], calpain [47,48] cathepsin proteases [49], and granzyme
Fig. 3. Different phases of Bax translocation to mitochondria. HL-1 cells were transfected with mito-DsRed2 to visualize mitochondria and GFP to follow changes in
subcellular localization of Bax during sI/R. In normoxic control cells GFP-Bax exhibits diffuse cytosolic and nuclear fluorescence distributed equally throughout the
cell (upper panels). (A) Starting in ischemia and extending into the reperfusion period, Bax translocates to the mitochondria, where it coats them homogeneously (data
not shown). By the time cells have completed 2 h ischemia and 5 h reperfusion, GFP-Bax is found as clusters surrounding individual swollen mitochondria (lower
panels). Scale bars, 10 μm. (B) GFP-Bax expressing cells were subjected to sI/R with or without 1 μM CsA. At 5 h of reperfusion, cells were classified as displaying
diffuse cytosolic or punctate mitochondrial GFP-Bax localization. The percentage of cells with punctate GFP-Bax distribution per total cells scored is represented as
the mean±S.E.M. of three independent experiments, each performed in duplicate. CsA significantly reduced redistribution and clustering of GFP-Bax at the
mitochondria (*P<0.05). Identical results were obtained with mCherry-Bax.
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induced Bid cleavage in the perfused whole heart model [47],
Bid cleavage has been attributed to varying proteases dependingon the death stimulus and cell type (e.g., caspase 8 in
cardiomyocytes vs. caspase 9 in endothelial cells in response
to I/R in the isolated heart [52]).
Fig. 4. Bax translocation to mitochondria independent, of mitochondrial dysfunction. (A) Subcellular localization of mCherry-Bax(wt) and mCherry-BaxT182A. Cells
were co-transfected with mCherry-Bax constructs and mito-ECFP and cells were imaged in KH solution. Whereas mCherry-Bax(wt) was found to be homogeneously
distributed throughout the cell, mCherry-BaxT182A was found to coat the mitochondrial networks of the cell. (B) Effect of Bax expression on ΔΨ. Transfected HL-1
cells were incubated in the green fluorescing ΔΨ-sensitive probe Rhodamine 123 (Rhod123, 50 nM) for 30 min in KH solution, and subsequently Z-stacks were
obtained. Cells expressing mCherry-Bax or mCherry-BaxT182A exhibited similar levels of filamentous, polarized mitochondria. Note that a non-transfected
neighboring cell demonstrates a similar degree of Rhod123 loading and filamentous mitochondrial structure, indicating that expression of the Bax fusion proteins do
not affect mitochondrial function. (C) Effect of Bax mitochondrial localization on cell injury and effect of p38 inhibition on Bax activation. At reperfusion, the extent
of clustering of mCherry-BaxT182A was similar to wild-type mCherry-Bax. T182A Bax formed significantly more clusters than WT Bax following 5 h reperfusion
(P<0.01). Following sI/R, HL-1 cells expressing either mCherry-Bax or mCherry-BaxT182A were reperfused in KH solution with or without SB203580 (10 μM).
Transfected cells were scored for Bax clustering at 5 h reperfusion. SB203580 significantly decreased the percentage of cells with Bax clustering in both mCherry-Bax
and mCherry-BaxT182A expressing cells (P<0.01). (D) SB203580 effect on mitochondrial morphology. At 5 h reperfusion, decreased mCherry-Bax and or mCherry-
BaxT182A clustering correlated with recovery of mitochondrial networks as revealed by imaging of mito-ECFP. mCherry-Bax was homogeneously distributed
following SB203580 treatment at reperfusion.
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in sI/R-induced Bid cleavage in HL-1 cells, we inserted a point
mutation within the caspase 8 cleavage site of Bid, generating
BidΔcasp8, and subcloned it into the Bid biosensor. TNF-α
activates programmed cell death involving caspase 8 dependent
cleavage of Bid [15]. Treatment of HL-1 cells transfected with
either Bid-sensor or BidΔcasp8-sensor with TNF-α resulted in
the cleavage of Bid-sensor but not BidΔcasp8-sensor, indicat-
ing successful mutation of the caspase 8 cleavage site (Fig. 6A).
Cells expressing the BidΔcasp8-sensor were subjected to 2 h
ischemia and 6 h reperfusion. The BidΔcasp8 cleavage product
was not detected although the cleavage product could be
detected in cells expressing the wild type Bid-sensor (Fig. 6A).
Likewise, inhibition of caspases with 50 μM zVAD-fmk
inhibited sI/R-induced cleavage of ectopically expressed Bid-
sensor as well as endogenous Bid, while the addition of 10 μM
ALLN, an inhibitor of calpain and cathepsins B and L, did not
affect Bid cleavage (Fig. 6B). These results indicate that caspase
8 is responsible for Bid cleavage after sI/R of HL-1 cardiac
myocytes.3.7. Spatio-temporally resolved interplay of Bid and Bax at the
mitochondria
During the preceding experiments, we noted that Bid
truncation and translocation to the mitochondria occurred at a
later time point than mitochondrial Bax translocation and
clustering. In order to resolve the spatio-temporal interplay of
Bid and Bax at the mitochondria, we transfected cells with both
mCherry-Bax and YFP-Bid-CFP. Under control conditions both
mCherry-Bax and YFP-Bid-CFP were distributed homoge-
neously throughout the cell. However, after 2 h ischemia and 5 h
of reperfusion, mCherry-Bax was detected at the mitochondria,
mainly in the absence of YFP-Bid-CFP redistribution, which
could be detected more frequently at later times. These results
are consistent with the notion that Bax translocation and
activation at the mitochondria occurs prior to massive Bid
activation (Fig. 7A). Although tBid is thought to function in
concert with Bax [53,54], we found that Bid did not localize to
the Bax clusters but instead displayed a homogeneous
mitochondrial distribution (Fig. 7B).
Fig. 5. YFP-Bid-CFP sensor to monitor Bid activation. (A) Cells were transfected with YFP-Bid-CFP and analyzed by 3D fluorescence imaging under control
conditions and after 2 h ischemia and 6 h reperfusion. Under control conditions, both CFP and YFP signals of Bid exhibit diffuse fluorescence. Following 6 h of
reperfusion, Bid-CFP (C-terminal fragment) exhibits a punctate distribution resembling mitochondria, while YFP-Bid (N-terminal fragment) remains diffusely
distributed. (B) After sI/R, Bid-CFP co-localizes with mito-DsRed2 visually confirming the mitochondrial localization of activated tBid-CFP.
Fig. 6. Bid cleavage during sI/R is mediated by caspase 8. (A) HL-1 cells were transfected with either Bid-sensor (WT) or Bid?casp8-sensor (M) and treated with TNF-
α (100 ng/ml) for 24 h. Proteins of whole cell lysates were separated by SDS-PAGE, transferred to nitrocellulose, and probed with anti-FP antibody to detect WT and
M Bid-sensor (78 kDa) and cleavage product tBid-CFP (42 kDa). (B) Bid-sensor expressing cells were subjected to 2 h ischemia followed by 6 h reperfusion in the
presence of the protease inhibitors ALLN (10 μM) or zVAD-fmk (50 μM). Western blots of whole cell lysates were probed with anti-FP, anti-Bid, and anti-actin
antibodies.
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In this study, we investigated mitochondrial remodeling in
conjunction with Bax and Bid redistribution in immortalized
cardiac HL-1 cells subjected to simulated ischemia/reperfusion
(sI/R). By combining 4D fluorescence imaging of GFP-mutant
fusion proteins, potentiometric dyes, and Western blotting, we
were able to characterize the dynamics of the pro-apoptotic Bcl-
2 family members Bax and Bid [6,7] in relation to mitochon-
drial remodeling and depolarization (Fig. 8).
Our data reveal a sequence of events during sI/R.
Mitochondrial fragmentation develops during ischemia and is
evident in nearly all cells by the end of 30 min simulated
ischemia. At reperfusion, MPTP-mediated ΔΨm collapse
occurs, coinciding with enhanced ROS generation by theFig. 7. Sequential activation of Bax and Bid in response to sI/R. (A) HL-1 cells were
were detected under control conditions (2+5 h KH solution) and after 2 h simulated is
mitochondria, HL-1 cells transfected with Bid-sensor and mCherry-Bax were subje
microscopy. Z-stack was 3D-rendered using the VolumeJ plugin [62] for ImageJ (
mCherry-Bax (clusters) and tBid-CFP (homogeneous mitochondrial pattern).mitochondria. Although previous studies have shown that loss
of ΔΨm occurs following Bax and Bid translocation, our data
indicate that in this model, MPTP activation is upstream of Bax
clustering. As CsA inhibited Bax clustering, our results support
the notion that MPTP activation is an upstream event for the
death signal cascades [43,55].
4.1. Mitochondrial dysfunction and Bax translocation
Bax translocation occurs in two phases, a priming phase
in which Bax coats the mitochondria homogeneously, and
an activation phase in which Bax forms discrete clusters
on the mitochondria. The coating phase occurs during
ischemia and early reperfusion, whereas clustering occurs
hours later. Both phases were sensitive to SB203580, andco-transfected with mCherry-Bax and YFP-Bid-CFP. CFP and mCherry signals
chemia and 5 h reperfusion. (B) To determine whether tBid and Bax colocalize at
cted to 2 h ischemia followed by 6 h reperfusion and analyzed by fluorescence
rsb.info.nih.gov/ij). 3D rendering reveals the distinct pattern of distribution of
Fig. 8. Time-line of events during sI/R in HL-1 cells. Scheme is an approximate representation reflecting the observed sequence of events during sI/R. Importantly, no
causal relationships are implied. Bax translocation can start during ischemia; however, it is more prevalent during reperfusion. Mitochondrial networks can be re-built
during reperfusion in the presence of SB203580.
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consistent with the recent report by Capano and Crompton
[41], who showed that Bax translocation to mitochondria
during ischemia was dependent on p38. p38 is a
downstream effector of AMPK activity, mediating diverse
effects including VEGF expression [56] and glucose uptake
[57]. Crucial molecular studies remain to be done with
AMPK.
Bypassing the translocation phase via expression of
mCherry-BaxT182A, which results in spontaneous Bax
translocation to mitochondria, resulted in accelerated cluster-
ing during reperfusion. Importantly, Bax translocation alone
was not sufficient to induce mitochondrial dysfunction,
indicating that downstream events are critical in the
activation of PCD.
We observed mitochondrial fragmentation in > 90% of the
cells at the end of the 2 h simulated ischemia and
mitochondrial fragmentation occurred before Bax transloca-
tion. This differs from a report [37], by Youle's group which
described Bax translocation before fragmentation. Mitochon-
drial fragmentation may represent an important event during
sI/R. Proteins involved in maintaining morphology are linked
to Bax activation and cytochrome c release [37,58,59]. A
recent study by Crompton's group showed Bax coating
filamentous mitochondria in cardiomyocytes prepared from
14 d old rat pups subjected to simulated ischemia (with
glucose deprivation and cyanide) [41]. These differences may
be due to the different cell types, stimuli, and time points
employed in each model.
Mitochondrial fragmentation may represent an important
response to ischemia. Interestingly, at 5 h of reperfusion,
SB203580-treated cells displayed elongated mitochondria,
demonstrating that in the absence of Bax and p38 signaling,
recovery of mitochondrial filamentous morphology was
possible, supporting the notion of a relationship between
Bax and the morphology machinery [37,59]. Fragmented
mitochondria are still polarized at reperfusion (data not shown)and we hypothesize that fragmentation is not a commitment to
cell death but rather may serve to limit mitochondria-to-
mitochondria propagation of pro-apoptotic signaling [60] as
well as to facilitate removal of damaged mitochondria by
autophagy.
4.2. Bid activation and translocation
A surprising finding was that Bid activation, via caspase 8,
occurred downstream of Bax clustering. It is possible that we
cannot detect subtle influences, but only cascade events.
Previous studies have shown that Bid may function to
stimulate or amplify the cell death program by sequestering
Bcl-2/xL [61]. One possibility for the relationship between
Bid and Bax is that at sub-detection levels tBid potentiates
Bax clustering, and the second (obvious) phase of Bid activity
involves massive destruction to the mitochondria, ensuring
the point of no return. Another possibility is that in this
model, Bid is simply a bystander that undergoes processing at
the time of general caspase activation. Further work will be
needed to establish the role of Bid in this system. Recently,
Bid has been shown to act as a switch between PCD I
(apoptosis) and II (autophagic cell death). Our findings that
Bid cleavage is caspase 8-dependent in HL-1 cells is at
variance with our previous studies in isolated perfused hearts
which showed that Bid cleavage was mediated by calpain
[46,47], but is consistent with another study [52]. Calpain
activation after global ischemia has been attributed to
excessive preload [63], which would be absent from this
cell-based model. This emphasizes the importance of
performing validation studies in the intact heart in the near
future.
4.3. Summary
Our studies demonstrate that sI/R in HL-1 cardiac myocytes
leads to mitochondrial dysfunction, reflected by loss of ΔΨm,
677N.R. Brady et al. / Biochimica et Biophysica Acta 1757 (2006) 667–678increased ROS generation, and fragmentation of mitochondria.
In addition, sI/R injury culminates in redistribution of Bax and
Bid, and finally cell death, revealing a carefully orchestrated
cell death program. The use of multicolor live-cell imaging
enabled us to investigate the spatio-temporal behavior of Bax
and Bid during ischemia and reperfusion, allowing unprece-
dented inquiry into the relationship between sI/R and
mitochondrial dysfunction pathways.
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